Xeris Biopharma Holdings, Inc. (XERS) Profit Margin
Xeris Biopharma Holdings, Inc. (XERS) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -247.48% |
| 2022-12-31 | -85.86% |
| 2023-03-31 | -50.71% |
| 2023-06-30 | N/A |
| 2023-12-31 | -37.98% |
| 2024-12-31 | -27.00% |
| 2025-12-31 | 0.19% |
How XERS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| MCK | McKesson Corporation | 1.18% |
| MOH | Molina Healthcare Inc | 1.04% |
| CVS | CVS Health Corporation | 0.44% |
| ICUI | ICU Medical Inc. | 0.03% |
| BRKR | Bruker Corporation | -0.25% |
These are five companies in the same sector as XERS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("XERS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XERS | $8.60 | +3.24% | 1.36M |
| 3 | ||||
| 4 | ||||
| 5 |